◂ Announcements

Dec 31, 2024ACQUISITIONChina

Shinva Medical Instrument to acquire 36.19% stake in Wuhan Zhongzhi Biotechnologies for $22.8M

Shinva Medical Instrument Co., Ltd announced it will acquire a 36.1913% stake in Wuhan Zhongzhi Biotechnologies Inc. for RMB166.5 million (USD22.8 million) to expand its in vitro diagnostics (IVD) product pipeline.

Value

$22.8M (166.5M CNY)

Status

Announced

ProductsRNA molecule in vitro diagnostic (IVD) kitsrespiratory infection pathogen detection kitsreproductive tract infection pathogen detection kitsintestinal infection pathogen detection kits

CompaniesShinva Medical Instrument acquirer Wuhan Zhongzhi Biotechnologies target

Sectors#Medical Devices

“Shinva Medical expects to significantly bolster its IVD product pipeline, thereby enhancing its overall competitiveness in the medical diagnostics market.”flcube.com

1 source
flcube.comShinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion - Insight, China's Pharmaceutical IndustryFineline CubeDec 31, 2024

Summarized from public sources; check the original articles before acting on it.

Similar announcements

May 30, 2025ACQUISITIONChina$23.6M
Microport Cardioflow to acquire full ownership of MP Cardioadvent
MicroPort CardioFlow Medtech acquirer La Ronda target tradingview.com flcube.com
May 22, 2025ACQUISITIONChina$45.0M
Shanghai INT Medical Instruments to acquire 51.7% stake in Endonom Medical
Shanghai INT Medical Instruments Co., Ltd. acquirer Endonom Medical (Hangzhou) target flcube.com
Dec 22, 2024ACQUISITIONChina
Haier Biomedical to merge with RAAS Blood Products
Haier investor Haier Biomedical acquirer www2.yicaiglobal.com
Dec 19, 2024ACQUISITIONChina$31.5M
INT Medical Instruments to acquire controlling stake in Weiqiang Medical Technology for RMB 230 million
Hangzhou Weiqiang Medical Technology target INT Medical Instruments Co., Ltd. acquirer flcube.com
Dec 18, 2024ACQUISITIONHangzhou, China$28.0M
Yingtai Medical to acquire at least 51% of Hangzhou Weiqiang Medical Technology
Yingtai Medical acquirer Hangzhou Weiqiang Medical Technology target beta.zhitongcaijing.com
Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com

Loading…